Bio-Path Holdings, Inc. (BPTH) vs ZyVersa Therapeutics, Inc. (ZVSA)
Bio-Path Holdings, Inc. and ZyVersa Therapeutics, Inc. are both Biotechnology companies. Bio-Path Holdings, Inc. is the larger, with a market value of $1.1M against $970.0K — 1.1× the size. Across the 7 metrics below, Bio-Path Holdings, Inc. leads on 4 and ZyVersa Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | BPTH | ZVSA | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | 157.01% | 817.13% | (57.72%) |
| Return on assets | (605.50%) | (225.42%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack